A modified heterotopic auxiliary living donor liver transplantation: report of a case
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 3
Abstract
Liver transplantation is regarded as an effective treatment for Wilson’s disease (WD), and recently has been shown to improve not only hepatic but also neurologic manifestations. Conventional auxiliary liver transplantation for WD is orthotopic liver transplantation and heterotopic liver transplantation. But the conventional procedure could not avoid the problem of space, functional competition, hemodynamic variation. Here we report a case of heterotopic auxiliary living-donor liver transplantation (HALDLT) to treat WD. We modified the operation to have a splenectomy, implant graft into the splenic fossa. The patient recovered well after the transplantation and has been symptom-free during a 5-year follow-up. This modified operation is more safe and simple. HALDLT might be an effective treatment for WD patients with splenomegaly.
Authors and Affiliations
Dou Kefeng , Wang Desheng , Tao Kaishan , Yue Shuqiang , Ti Zhenyu , Song Zhenshun , Li Lin , He Yong , Hou Xiaojuan
Keywords
Related Articles
- EP ID EP78404
- DOI -
- Views 131
- Downloads 0
Meta-analysis of the clinical value of oxymatrine on sustained virological response in chronic hepatitis B
Introduction. Oxymatrine (OMTR) is widely used for the treatment of chronic hepatitis B (CHB) in China. Several recent reportsrevealed that OMTR together with interferon yielded a higher sustained virological response (...
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
Liver biopsy is the recognized gold standard for liver fibrosis staging. The aspartate aminotransferase to platelet ratio index (APRI) has been proposed as a noninvasive and readily available tool for the assessment of l...
Hepatocellular adenoma: different entities for a single lesion
Mortality trends for liver cancer in Mexico from 2000 to 2006
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, with an estimated incidence of half a million new cases per year around the world. Furthermore, HCC is the third greatest cause of cancer-related de...
Gut microbiota and nonalcoholic fatty liver disease
Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance the extraction of energy f...